TENSHA THERAPEUTICS
Tensha Therapeutics is developing small molecule bromodomain inhibitors, a new class of epigenetic modulators of gene expression, to treat cancer and other serious disorders. The companyรขโฌลธs programs are based on the discovery from the laboratory of Dr. James Bradner at Dana-Farber Cancer Institute of first-in-class, potent small molecule BET bromodomain inhibitors. The companyรขโฌลธs lead program is aimed at the treatment of patients with BRD4-NUT midline carcinoma, acute myeloid leukemias, multiple myeloma, and other diseases. Tensha is a Focused Company funded by HealthCare Ventures.
TENSHA THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Pharmaceutical
Founded:
2011-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.tenshatherapeutics.com
Total Employee:
10001+
Status:
Active
Contact:
+41 61 688 11 11
Email Addresses:
[email protected]
Total Funding:
15 M USD
Technology used in webpage:
SPF Safenames
Similar Organizations
Cullinan Pearl
Cullinan Pearl develops an orally available tyrosine kinase inhibitor to target Epidermal Growth Factor Receptor exon 20 mutations.
GIRx
GIRx is developing small molecule agents to treat diabetes, obesity and other metabolic conditions.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Investors List
Torrey Pines Investment
Torrey Pines Investment investment in Funding Round - Tensha Therapeutics
HealthCare Ventures
HealthCare Ventures investment in Series A - Tensha Therapeutics
Official Site Inspections
http://www.tenshatherapeutics.com
- Host name: redirect.idp365.net
- IP address: 217.19.248.132
- Location: Milton Keynes United Kingdom
- Latitude: 52.0675
- Longitude: -0.7569
- Timezone: Europe/London
- Postal: MK14
